Skip to main content
. 2017 Jun 12;13(9):2138–2149. doi: 10.1080/21645515.2017.1337614

Figure 1.

Figure 1.

Actual proceedings in the RSV vaccine and monoclonal antibody development (Adapted from Ref. 115.)